Tafnat Tablets – Tenofovir Alafenamide 25 mg
Description
Tafnat Tablets contain Tenofovir Alafenamide 25 mg, an antiviral medicine used primarily for the management of chronic hepatitis B virus (HBV) infection. Tenofovir Alafenamide belongs to the nucleotide reverse transcriptase inhibitor class and works by reducing the ability of hepatitis B virus to multiply in the body.
This product page provides information about Tafnat Tablets, including their composition, uses, mechanism of action, dosage considerations, side effects, storage and frequently asked questions.
Tafnat Tablets Composition
Each film-coated tablet contains Tenofovir Alafenamide 25 mg. The medicine is generally supplied as tablets for oral administration. Product information indicates that treatment should be initiated and monitored by a healthcare professional experienced in managing chronic hepatitis B.
Tafnat Tablets Uses
Tafnat Tablets are used for the treatment of chronic hepatitis B infection in appropriate patients. Hepatitis B is a viral infection that affects the liver and may become long-term, potentially causing progressive liver damage if not properly managed.
Tenofovir Alafenamide works by inhibiting viral replication. Continued treatment as prescribed can help control HBV levels and support long-term management of the infection. It is important to understand that antiviral treatment should be taken under medical supervision and does not replace regular monitoring of liver health.
How Tafnat Tablets Work
Tenofovir Alafenamide is converted inside cells to its active form, tenofovir diphosphate. This active compound interferes with the viral replication process by inhibiting the HBV reverse transcriptase enzyme.
By reducing viral replication, Tenofovir Alafenamide helps suppress the amount of hepatitis B virus in the body. Regular treatment and appropriate medical follow-up are important for maintaining viral suppression.
Tafnat Tablets Dosage and Administration
The appropriate dose and treatment duration should be determined by a qualified healthcare professional. Product information for Tenofovir Alafenamide 25 mg indicates one tablet once daily for indicated adults and adolescents meeting the specified age and weight criteria.
Patients should take the medicine exactly as prescribed and should not stop long-term treatment without consulting their healthcare provider. Stopping antiviral therapy abruptly may result in worsening of hepatitis B.
Possible Side Effects
Some patients may experience side effects while taking Tenofovir Alafenamide. Reported effects can include:
Headache
Nausea
Diarrhea
Abdominal discomfort
Dizziness
Joint or muscle pain
Fatigue
Skin rash
Patients with persistent or severe symptoms should contact their healthcare professional. People with existing kidney or liver conditions should inform their doctor before starting treatment. Regular medical monitoring may be recommended during therapy.
Storage and Handling
Store Tafnat Tablets according to the instructions provided with the product. Product information commonly specifies storage below 30°C. Keep the tablets in their original packaging, protected from unsuitable environmental conditions, and out of reach of children.
Buy Tafnat Tablets from a Pharmaceutical Supplier
Tafnat Tablets containing Tenofovir Alafenamide 25 mg may be sourced through authorized pharmaceutical supply channels, subject to prescription, import requirements and applicable regulations in the destination country.
For pharmaceutical procurement, buyers should verify product specifications, packaging, documentation, quantity requirements and applicable import regulations before placing an order.
Frequently Asked Questions
What are Tafnat Tablets used for?
Tafnat Tablets contain Tenofovir Alafenamide 25 mg and are primarily used for the management of chronic hepatitis B virus infection.
What is the active ingredient in Tafnat Tablets?
The active pharmaceutical ingredient is Tenofovir Alafenamide 25 mg.
How does Tenofovir Alafenamide work?
It inhibits an enzyme required for hepatitis B virus replication, thereby reducing the virus's ability to multiply.
How should Tafnat Tablets be taken?
Take the medicine exactly as prescribed by your doctor. The appropriate dosage depends on the patient's medical condition and clinical requirements.
Can I stop Tafnat Tablets when I feel better?
Do not stop treatment without medical advice. Hepatitis B can become active again after antiviral treatment is discontinued, so follow-up with a healthcare professional is important.
What are the common side effects?
Possible side effects include headache, nausea, diarrhea, abdominal discomfort, dizziness, fatigue and joint or muscle pain.
Do Tafnat Tablets require a prescription?
Tenofovir Alafenamide is a prescription medicine. It should be used under the supervision of a qualified healthcare professional.







